The circadian clock is an endogenous oscillator that controls behavior and physiology of organisms ranging from Neurospora to mammals. In most cases, this oscillator is linked to darklight cycles (1) (2) (3) (4) . Light provides an initiating event to reset the clock, thereby maintaining periodicity with environmental cycles. The central mechanism underlying circadian clocks is a cell autonomous autoregulatory transcriptional feedback loop. In Drosophila, two basic helix-loop-helix transcription factors, Cycle (Cyc) and Clock (Clk), form a heterodimeric complex that binds to E-box promoter sequences to activate the expression of a variety of genes important for establishing circadian clock output (5) (6) (7) (8) . Among the genes regulated by Cycle/Clock are the Period (Per) and Timeless (Tim) genes (9, 10) . Current data indicate that Tim functions primarily to stabilize Per in the cytoplasm (11, 12) . In response to appropriate signals, newly synthesized Per and possibly Per-Tim complexes translocate to the nucleus where Per functions to repress the Cyc-Clk complex and inhibit transcription. Thus, interaction between Clk/ Cyc and Per forms the basis of a transcriptional feedback loop (2, 3, 4, 8) . The cryptochrome (Cry) 1 proteins function as photoreceptors and link light signals to the central clock by regulating Clk/Cyc activity (13) .
In mammals, the components of the system are structurally related, but the gene families are often expanded. Clock interacts with the Bmal-1 transcription factor to form a complex analogous to Cyc/Clk. However, there are three Per-related genes in mammals (PER1, PER2, and PER3). The available data indicate that Per1 and Per2 play primary roles in circadian rhythms (14 -17) . In addition, two distinct Cry genes are present in mammals (18) . Current data suggest that Cry proteins bind Period proteins in the cytoplasm and may facilitate nuclear transport (reviewed in Ref. 8 and see Refs. 19 and 20) . Cry proteins also interact with the Clk-Bmal-1 complex and may repress this complex independently of Period and Timeless (17) . Thus, the potential to form multiple temporally distinct higher order complexes exists.
Post-translational regulation of Per also plays an important role in establishing the circadian clock. Indeed, in flies constitutive expression of Per in per 01 (per null) flies restores behavioral rhythms (21) , suggesting that the major mechanisms controlling periodicity involves post-translational mechanisms. The mechanisms appear to control both the activity status of Per as well as its stability, and regulated proteolysis may underlie the periodic control of clock-dependent gene expression by relieving the repressive activity of Period. Two protein kinases, Doubletime (Dbt) and casein kinase II (CKII), have been implicated in the regulation of Per in Drosophila (22, 23) . In addition, Shaggy/GSK3 has been implicated in the control of Tim translocation into the nucleus and may regulate Per indirectly (24) . Recent data indicate that phosphorylation by Dbt controls both the stability of Per and its repression activity (12, 23, 25, 26) , although CKII may control nuclear import and repressor activity (12, 23) . Although CK1⑀ has been proposed to control nuclear translocation of Per1 in mammalian systems (27) , recent data in Drosophila suggest that this may be an indirect effect of tight interaction of phosphorylated Per with chromatin (12). However, CKI⑀ is also thought to promote degradation of Per both in Drosophila and mammals through the ubiquitin proteasome pathway (28, 29) .
Turnover of proteins through the ubiquitin proteasome pathway involves three major activities as follows: E1 ubiquitinactivating protein that uses ATP to form a high energy thiol ester with the C terminus of ubiquitin; an E2 ubiquitin-conjugating enzyme that receives ubiquitin from E1 and transfers it to lysine residues in the substrate; and E3 ubiquitin ligase that serves to bind both the E2 and the substrate, thereby facilitating transfer of ubiquitin to the substrate (reviewed in Ref. 30) . Multiple rounds of ubiquitination on the initial ubiquitin conjugate lead to formation of a polyubiquitin chain that is recognized by the proteasome, resulting in degradation of the ubiquitinated protein. One of the best understood E3s is the SCF ubiquitin ligase (31, 32) . These complexes are composed of Cul1, which serves as a scaffold for assembly of ubiquitin conjugation and substrate-binding components (reviewed in Refs. 33 and 34) . The C terminus of Cul1 binds to the Rbx1 Ring finger protein (also called Roc1), which in turn binds to the E2 ubiquitin-conjugating enzymes (35) (36) (37) . The N terminus of Cul1 interacts with Skp1, which interacts in turn with proteins containing the F-box motif (31, 38, 39) . F-box proteins (38, 40) frequently contain C-terminal domains that interact with phosphorylated substrates (see Refs. 31, 41, and 42 and reviewed in Ref. 34) . Thus the SCF system provides a primary route for phosphorylation-dependent degradation of proteins. Previous studies have suggested a role for the F-box protein Slimb in turnover of Drosophila Per (22, 43) . Slimb (slmb) is the fly isolog of ␤-TRCP (44), a well characterized mammalian F-box protein important for degradation of a number of different regulatory proteins, including IB, ␤-catenin, Emi1/2, the interferon-␣ receptor, and Cdc25A (45) (46) (47) (48) (49) (50) (51) (52) . slmb mutant flies are arrhythmic, but this defect can be restored by expression of SLMB in clock neurons (22) . In addition, Drosophila Per interacts with SLMB in a manner that requires Dbt (22, 43) . ␤-TRCP and SLMB are known to interact with phosphodegrons containing the sequence Asp-phospho-Ser-Gly-Phe/Ile-X-phospho-Ser found in a number of well characterized substrates (41) . However, both Drosophila and mammalian Period proteins lack this sequence, bringing into question whether the interaction is direct. Moreover, SLMB has not been shown to directly ubiquitinate Per in vitro.
In this study, we have examined the role of phosphorylation and the ubiquitin machinery in the degradation of mammalian Per1 in tissue culture cells. Systematic examination of 10 CK1 family members indicates that CK1⑀ and CK1␥2 can promote proteasome-dependent Per1 degradation in mammalian tissue culture cells, and their removal by RNAi leads to an increased abundance of Per1. As expected, CK1⑀ interacted with Per1 in transfected cells, as did CK1␥2. We found that dominant negative Cul1 (but not Cul3) stabilized Per1, suggesting an F-boxmediated degradation pathway. We surveyed two dozen F-box proteins for CK1⑀-dependent binding to Per1 and identified ␤-TRCP1 and ␤-TRCP2 as phosphorylation-dependent binding proteins for Per1. Simultaneous knock-down of ␤-TRCP1 and ␤-TRCP2 leads to stabilization of Per1. Interaction of ␤-TRCP with Per1 involves sequences located near the N terminus of the protein in a region distinct from the previously characterized CK1⑀ binding domain (28, 29) . Ubiquitination of Per1 in vitro by SCF ␤-TRCP required that Per1 be previously phosphorylated with CK1⑀, and CKII was not effective in promoting Per1 ubiquitination in this setting. Finally, overexpression of ␤-TRCP and CK1⑀ resulted in stimulation of Clock/Bmal-1-dependent gene transcription as assessed by using an E-box reporter construct, whereas knock-down of ␤-TRCP resulted in a dramatic decrease in Clock/Bmal-1-dependent transcription. Taken together, these data suggest that SCF ␤-TRCP collaborates with CK1⑀ to promote turnover of Per1 in mammalian cells, thereby controlling the activity of the Clock transcription factor complex.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection-HEK293T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. The cells were seeded 24 h prior to transfection. Transfection was performed with Lipofectamine 2000 (Invitrogen). After transfection, the cells were incubated for 48 h and harvested. For the knockdown by short hairpin RNA (shRNA), dual transfections were performed as described previously (50) . Sf9 cells were cultured in INSECT-EXPRESS medium (BioWhittaker) supplemented with 10% fetal bovine serum. Bac-N-Blue constructs expressing FLAG-CKI⑀ were transfected into Sf9 cells using Cellfectin (Invitrogen).
DNA Constructs-Human PER1 gene and casein kinase genes were generated by PCR and cloned into pENTR-D (Invitrogen). For expression, pENTR constructs were recombined using Clonase (Invitrogen) with the indicated epitope-tagged vectors for mammalian expression or Bac-N-Blue vectors for expression in insect cells. Open reading frames for the indicated F-box proteins (50) and CK1 isoforms (produced by PCR from full-length EST clones) were ligated into pENTR6 and subsequently recombined into pDEST-CMV-GST, pCMV-GFP, or pCMVMyc vectors. Mutants of Per1 (5SA or FA) or CKI⑀ (K38R) were generated by PCR and verified by DNA sequencing.
Immunoprecipitation and Western Blotting-The indicated cells were lysed in extraction buffer (25 mM Tris-Cl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA, 5 mM NaF) containing EDTA-free protease inhibitor tablets (Roche Applied Science). In some experiments, cycloheximide (25 g/ml) was added before harvesting cells. In some experiments, MG132 was added at the indicated concentrations (1.0 or 2.0 M) 15 h before lysis. Extracts were subjected to direct Western blot analysis or immunoaffinity purification using indicated affinity reagent. Anti-GST (Z-5) and anti-Myc (9E10) were from Santa Cruz Biotechnology. Anti-FLAG (M2) was from Sigma. Anti-Cul1, anti-CDC25A, and anti-Per1 were from Zymed Laboratories Inc., Neomarker, and Affinity BioReagents, respectively. Anti-TRCP was from a previous study and has been shown to interact with both ␤-TRCP1 and ␤-TRCP2 (53) . To verify the knock-down of ␤-TRCP, phosphorylated ␤-catenin beads were used to concentrate the amount of ␤-TRCP prior to immunoblotting as described previously (50) .
In Vitro Kinase Reactions and in Vitro Ubiquitination ReactionsSf9 cells infected with FLAG-tagged CKI⑀ were lysed in NETN buffer and purified by FLAG M2 beads (Sigma). CKI⑀ protein was eluted using FLAG M2 peptide (Sigma). 35 S-Labeled and in vitro translated Per1 was incubated with purified CKI⑀ (100 ng) or CKII (Biolabs) at 37°C for 30 min. Per1 proteins were separated by 4 -12% Tris glycine SDSpolyacrylamide gradient mini gels (Invitrogen) prior to autoradiography. Per1 ubiquitination was performed using phosphorylated or nonphosphorylated in vitro translated Per1 (2.5 l) in the presence of E1 ubiquitin-activating enzyme (50 ng), Ubc5 (200 ng), ubiquitin (1 mg/ml), 1 M ubiquitin aldehyde (Boston Biochem), 2.3 l of in vitro translated ␤-TRCP, and 4 mM ATP in a total volume of 10 l (50 min, 27°C). SDS-PAGE separation was performed by 3-8% Tris acetate gradient mini gels (Invitrogen) prior to autoradiography.
Luciferase Reporter Assays-HEK293T cells were plated in 12-well dishes 12 h before transfection. Cells in each well were transfected with 20 ng of firefly luciferase reporter plasmid (either 54-mer E-box-Luc or 4R-Luc, both were gifts from Dr. S. Reppert, University of Massachusetts Medical School), 5 ng of SV40 Renilla luciferase reporter plasmid and the indicated amount of expression or shRNA plasmids for ␤-TRCP or Fbw7. Dual transfection was performed for the shRNA plasmids as described previously (50) . The total amount of DNA in each well was adjusted by adding pHR-myc expression plasmid as carrier. Forty eight hours after transfection, cells were harvested and lysed prior to determination of luciferase activity by luminometry. Firefly luciferase activity was normalized by determining the firefly/Renilla activity ratio from triplicate wells. All experiments were repeated at least twice.
RESULTS

Systematic Analysis of the Role of Casein Kinase 1 (CK1) Isoforms in the Control of Per1 Degradation-Previous studies
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indicate a role for casein kinase 1⑀ (CK1⑀) in control of Per1 turnover. However, the possible role of other CK1 isoforms has not been systematically examined. The CK1 family contains 10 family members, including ␣, ␦, ⑀, and ␥ and the vaccinia virus-related kinases (VRK) 1-3 (Fig. 1A) . These kinases contain highly conserved catalytic domains but have unrelated C-terminal extensions. In order to examine the potential of each CK1 protein to promote Per1 turnover, we developed an in vivo degradation assay. GST-Per1 and various CK1 proteins were transiently expressed in HEK293 cells. In control experiments lacking CK1 or in the presence of CK1 ␣1, ␣2, ␦, ␥1, ␥3, VRK1, VRK2, or VRK3, GST-Per1 accumulated to high levels (Fig. 1B) . In contrast, co-expression of Per1 with CK1⑀ or -␥2 resulted in little or no accumulation of GST-Per1 (Fig. 1B , lanes
FIG. 1. CKI⑀ and CKI␥2 interact with and promote the degradation of Per1.
A, the phylogenetic tree for the casein kinase 1 protein family. The tree was obtained using Clustal W. B, CKI⑀ and CKI␥2 promote degradation of Per1. GST-tagged Per1 and each of the Myc-tagged casein kinase 1 family members were co-expressed in HEK293T cells, and after 48 h lysates were subjected to immunoblotting with the indicated antibodies. WB, Western blot. C, degradation of Per1 by CKI⑀ or CKI␥2 requires the proteasome pathway. HEK293T cells were transfected with the vector expressing GST-tagged Per1 and either GFP-tagged CKI⑀ or CKI␥2. Thirty hours after transfection, the indicated concentrations of MG132 were added and incubated for more than 15 h prior to harvesting. Lysates were subjected to immunoblotting with the indicated antibodies. D, Per1 specifically associates with CKI⑀ and CKI␥2. HEK293T cells were transfected with vectors expressing GST-tagged Per1 and various CK1 family members as Myc-tagged fusion proteins. Thirty hours after transfection, 2 M MG132 was added and incubated for 15 h prior to harvesting. Association of CK1 proteins with GST-Per1 was determined after purification of GST-Per1 by using GSH-Sepharose by reactivity with anti-Myc tag (9E10) antibodies. E and F, knock-down of CK1 genes by shRNA stabilizes the endogenous Per1 protein. HEK293T cells were co-transfected with vectors expressing the indicated Myc-tagged CK1 proteins and shRNA vector targeting CK1⑀, CK1␥2, and CK1␥3 or shGFP as a control. Forty-eight hours after transfection, lysates were subjected to immunoblotting with the indicated antibodies (E). F, HEK293T cells were dual-transfected with shRNA vectors targeting the indicated casein kinases. 48 h after transfection, cells were harvested after incubation with CHX (25 g/ml) for indicated the time and lysed. Lysate (200 g) was subjected to immunoblotting with anti-Per1 antibody. Blot were reprobed with Cul1 as a loading control. G, a dominant negative form of Cul1 (DN-Cul1) blocks CKI⑀-dependent degradation of Per1 proteins. HEK293T cells were co-transfected with the vector expressing GST-tagged Per1, GFP-tagged CKI⑀, and the vectors expressing either an N-terminal fragment of Cul1 (residues 1-452, DN-Cul1) or N-terminal fragment of Cul3 (DN-Cul3) (62) . Forty-eight hours after transfection, cells were harvested after incubation with CHX (25 g/ml) for the indicated time and lysed. Lysates were subjected to immunoblotting with indicated antibodies, including anti-Cdc25A used as a positive control for Cul1-mediated degradation. IP, immunoprecipitation.
Per1 Turnover via the SCF
␤-TRCP Ubiquitin Ligase5 and 7). Importantly, addition of the proteasome inhibitor MG132 led to accumulation of GST-Per1 in the presence of either CK1⑀ or -␥2 (Fig. 1C) , indicating that the loss of GSTPer1 in this setting was proteasome-dependent. All CK1 proteins, when purified from transfected mammalian cells, displayed similar levels of activity toward the generic substrate casein and also displayed autophosphorylation activity (data not shown), indicating that the absence of activity in Per1 degradation was not a simple reflection of the absence of catalytic activity. Previous studies have indicated that CK1⑀ can form stable complexes with Per1 (20, 28, 29, 54) . The finding that CK1␥2 can promote Per1 degradation led us to ask whether CK1␥2 might also form a complex with Per1. GST-Per1 or GST as a negative control was co-expressed with all 10 CK1 isoforms tagged with an N-terminal c-Myc epitope in HEK293 cells, and GST-Per1 and associated proteins were purified by using GSHSepharose (Fig. 1D) . As expected, CK1⑀ stably associated with GST-Per1 (Fig. 1D, lane 10) but not with GST alone (lane 9). We also found that CK1␥2 formed stable complexes with GSTPer1 (Fig. 1D, lane 14) . In contrast, none of the other CK1 isoforms were found to associate with GST-Per1 (Fig. 1D) , indicating a high degree of selectivity for the interaction with CK1⑀ and -␥2.
We then examined the effect of depletion of CK1⑀ and CK1␥2 by RNAi of the stability of endogenous Per1 by RNAi. We developed shRNA vectors that knock-down expression of transiently expressed CK1⑀, CK1␥2, and CK1␥3 in HEK293 cells, when compared with an shRNA targeting GFP used as a control (Fig. 1E) . Cells expressing shRNA targeting CK1⑀ and CK1␥2 accumulate endogenous Per1 when compared with cells expressing shGFP, whereas cells expressing CK1␥3 has little effect (Fig. 1F) . These data indicate that CK1⑀ and CK1␥2 may contribute to Per1 turnover.
Involvement of SCF ␤-TRCP in Per1 Turnover-The finding that Per1 turnover requires phosphorylation by CK1 suggests the possible involvement of an SCF-based ubiquitin ligase. The vast majority of SCF substrates associate with F-box proteins in a phosphorylation-dependent manner (33, 34) . To examine whether the SCF is involved, we first employed cullin dominant negatives. Cullins interact with specificity modules via an Nterminal domain and with Rbx1/Rbx2 and UBCs via its Cterminal domain. Overexpression of the N-terminal domain of Cul1 and Cul3 sequesters F-box protein-substrate complexes thereby stabilizing substrates (55) . As shown in Fig. 1G , transient expression of Cul1 dominant negative (Cul1DN) blocked CK1⑀-mediated degradation of Per1. In contrast, Cul3DN did not block Per1 degradation in this assay. The pattern of stabilization was similar to that found with Cdc25A, a known target of the SCF (Fig. 1G) (50, 51) .
F-box proteins serve as substrate specific adaptors of SCF complexes. In order to identify F-box proteins that associate with Per1, we employed a panel of expression constructs for 21 F-box proteins in an in vivo Per1 binding assay. HEK293 cells were transfected with pCMV-Myc-Per1, pCMV-CK1⑀, and vectors expressing GST-F-box proteins. Prior to preparation of cell lysates, cells were treated with MG132 to block Per1 degradation. We found that both GST-␤-TRCP1 and GST-␤-TRCP2 associated efficiently with Per1, whereas none of the other F-box proteins examined were found to associate (Fig. 2, lanes  2 and 3) . ␤-TRCP1 and ␤-TRCP2 share extensive sequence identity and are thought to have overlapping activity but are the products of different genes. ␤-TRCP1 and ␤-TRCP2 are the mammalian counterparts of the Slimb protein implicated previously in the control of circadian rhythms in Drosophila (22, 43) .
To examine the interaction of endogenous ␤-TRCP and Per1, we employed HeLa cells previously transduced with a retrovirus expressing FLAG-HA-tagged Per1 under control of the long terminal repeat promoter. ␤-TRCP immune complexes contained both FLAG-HA-Per1 as well as Cul1, whereas neither protein was found in control immunoprecipitates containing rabbit IgG (Fig. 3B) .
The interaction of all known SCF ␤-TRCP substrates is phosphorylation-dependent. To examine whether association of Per1 with ␤-TRCP proteins was also phosphorylation-dependent, we performed binding experiments using extracts from cells expressing either active CK1⑀ or a kinase-dead CK1⑀ mutant protein. Although Per1 efficiently associated with ␤-TRCP proteins in cells expressing active CK1⑀, the interaction was greatly reduced in cells expressing kinase-dead CK1⑀, suggesting that the interaction was phosphorylation-dependent (Fig. 3A) .
Stabilization of Per1 in Cells Depleted for ␤-TRCP-To examine whether ␤-TRCP proteins are required for Per1 degradation, we turned to RNAi. We employed a shRNA expression 
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vector that depletes both ␤-TRCP1 and ␤-TRCP2 (Fig. 3C ) (50) . Cells were co-transfected with pCMV-GST-Per1 and pCMV-CK1⑀ in the presence of vectors expression FBW7 or ␤-TRCP shRNAs, and the levels of GST-Per1 were examined after addition of cycloheximide to block protein translation (Fig. 3E) . Although GST-Per1 was readily degraded in cells expressing shRNA against FBW7, it was dramatically stabilized in cells expressing shRNA against ␤-TRCP (Fig. 3E, compare lanes 1-3  with lanes 4 -6) . The extent of stabilization was similar to that observed with the previously identified ␤-TRCP target Cdc25A (Fig. 3E ) (50) . By using shRNAs that independently target ␤-TRCP1 and ␤-TRCP2, we found that depletion of either led to a small increase in the levels of GST-Per1 relative to cells expressing shRNA against GFP as a negative control (Fig. 3F, lanes  7-10) , whereas the extent of stabilization seen with ablation of both ␤-TRCP proteins together was significantly higher (lanes 5 and 6). These data indicate that both ␤-TRCP1 and ␤-TRCP2 contribute to GST-Per1 turnover in HEK293 cells.
FIG. 3. ␤-TRCP is required for CKI⑀-dependent degradation of Per1.
A, association of ␤-TRCP with Per1 is CKI⑀-dependent. HEK293T cells were co-transfected with vectors expressing FLAG-tagged Per1 and GST-tagged ␤-TRCP in the presence of vectors expressing either wild-type or kinase-dead (K38R) Myc-CKI⑀. Association of GST-␤-TRCP with FLAG-PER1 was determined after purification of ␤-TRCP-bound proteins using GSH-Sepharose. B, association of endogenous ␤-TRCP with Per1. Extracts from HeLa cells stably expressing FLAG-HA-Per1 derived from retroviral transduction (see "Experimental Procedures") were subjected to immunoprecipitation using anti-␤-TRCP antibodies (provided by Serge Fuchs, University of Pennsylvania). Immune complexes were separated by SDS-PAGE and subjected to immunoblotting with Per1 antibodies. Blots were subsequently stripped and reprobed with anti-Cul1 and anti-␤-TRCP. The position of IgG heavy chain is indicated by an asterisk. C and D, depletion of ␤-TRCP by shRNA stabilizes endogenous PER1 and blocks CKI⑀-dependent degradation of transfected Per1. C, HEK293T cells were dual-transfected with a shRNA vector targeting both ␤-TRCP1 and ␤-TRCP2. Forty-eight hours after transfection, cells were lysed, and extracts were subjected to binding reactions with an immobilized phosphodegron for ␤-TRCP or an unphosphorylated peptide in order to enrich for ␤-TRCP (50). After washing, bound proteins were immunoblotted with the indicated antibodies (see "Experimental Procedures"). As a control, crude extracts were probed with anti-Cul1 to demonstrate equal protein quantities used for the binding reaction. D, HEK293T cells were dual-transfected with shRNA vectors targeting either ␤-TRCP or Fbw7. Forty-eight hours after transfection, cells were harvested after incubation with CHX (25 g/ml) for the indicated time and lysed. Lysates (200 g) were subjected to immunoblotting with anti-Per1 antibody. Blots were re-probed with Cul1 as a loading control (E). HEK293T cells were co-transfected with the vectors expressing GST-tagged Per1, GFP-CKI⑀, and shRNA vectors targeting both ␤-TRCP1 and ␤-TRCP2. Forty-eight hours after transfection, cells were harvested after incubation with CHX (25 g/ml) for the indicated time. Lysates were subjected to immunoblotting with anti-GST, stripped, and reprobed with anti-Cdc25A (a known ␤-TRCP substrate) and anti-Cul1 as a loading control. F, ␤-TRCP1 and ␤-TRCP2 function redundantly in Per1 turnover. HEK293T cells were co-transfected with vectors expressing GST-Per1, GFP-CKI⑀, and shRNA vectors targeting either ␤-TRCP1, ␤-TRCP2, or a vector that targets both ␤-TRCP1 and ␤-TRCP2. Forty-eight hours after transfection, cells were harvested after incubation with CHX for the indicated time and lysed. Lysates were subjected to immunoblotting with anti-Per1 followed by re-probing with anti-Cul1 as a loading control. IP, immunoprecipitation; WB, Western blot.
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We then asked whether endogenous Per1 is stabilized by knock-down of ␤-TRCP proteins. HEK293 cells were transfected with vectors expressing shRNA against FBW7 or ␤-TRCP and Per1 levels examined. Whereas endogenous Per1 protein levels are very low in cells expressing shRNA against FBW7 (Fig. 1D, lanes 1 and 2) , it is readily detectable in cells expressing shRNA targeting ␤-TRCP (lanes 3 and 4) . Thus, endogenous Per1 is stabilized by ␤-TRCP.
Recognition of Per1 by ␤-TRCP Involves an N-terminal Region of Per1-␤-TRCP proteins are known to interact with substrates through a phosphorylated motif DpSG⌽XpS (where pS is phosphoserine and ⌽ is a hydrophobic residue). Substrates that contain such sequences include IB␣, ␤-catenin, and Emi1 (41). However, this specificity is not strictly maintained. For example, interaction of ␤-TRCP with the Cdc25A protein involves a motif containing the DpSG motif but lacking the second phosphoserine residue (50) . Similarly, Wee1 interacts with ␤-TRCP through a bi-partite sequence unrelated to the DpSG⌽XpS motif (56) . Analysis of the sequences of Period proteins indicates that these proteins lack a canonical ␤-TRCP recognition motif, raising the question of how ␤-TRCP proteins recognize Per1.
Previous studies have identified a central region of Period proteins as being important for interaction with CK1⑀ (28, 29, 54) . This region is highly conserved in Per1, Per2, and Per3 proteins and contains a cluster of phosphorylation sites that are modified by CK1⑀ (Fig. 4A) . In one study (28) , mutation of this cluster of sites in Per3 was found to alter the extent of mobility shift on SDS-PAGE observed in the presence of CK1⑀ as well as Per3 turnover in transfected cells (28) . The mechanism responsible for the effects on turnover are unknown. We found that ␤-TRCP associated with mouse Per3 with an efficiency similar to that found with human Per1 (Fig. 4B, lane 4) . Interestingly, mouse Per3 in which seven potential CK1⑀ residues in the CK1 binding region were replaced by alanine still maintained the ability to interact with ␤-TRCP in the presence of CK1⑀ (lane 6) and was subject to degradation upon coexpression of CK1⑀ (Fig. 4G) . These data indicate that these putative CK1⑀ phosphorylation sites are not required to recruit ␤-TRCP in Per3 or to promote degradation. We also examined whether conserved serine residues in this region of Per1 are also involved in ␤-TRCP recognition using the 5SA mutant (Fig. 4, A and C) . Cells were transfected with vectors expressing myc-␤-TRCP1, CK1⑀, and the GST-Per1 5SA mutant and treated with MG132 prior to examining proteins associated with GST-Per1 (Fig. 4C) . The Per1 protein lacking these presumptive CK1 phosphorylation sites maintained association with ␤-TRCP, indicating that these sequences are not required for binding (Fig. 4C, compare lanes 2 and 3) . Moreover, these mutations in either Per1 or Per3 do not affect the association with CK1⑀ (Fig. 4, B and C) .
Recent work has identified a potential docking sequence in the CK1 target NFAT that facilitates recognition by CK1 (57) . This sequence contains two phenylalanine residues flanking a degenerate 3-amino acid spacer (FXXXF). Per1 contains an FXXXF motif within the previously identified CK1 interaction domain (Fig. 4A) . To examine the importance of this motif to the recognition of CK1⑀ and ␤-TRCP, the two phenylalanines in this motif were mutated to alanine (Fig. 4A) . Mutation of the docking motif dramatically reduced association of Per1 with CK1⑀, and this reduction was paralleled by a reduction in the binding of ␤-TRCP (Fig. 4C, lane 4) . However, residual association was observed, suggesting that other sequence elements are involved in recognition of CK1⑀ and ␤-TRCP by Per1.
In order to begin to identify sequences in Per1 that allow interaction with ␤-TRCP, we employed deletion mutants in Per1. Three mutants were prepared that span the entire length of Per1 (1-430, 431-830, and 831-1290) . These mutants were co-expressed as GST fusions together with CK1⑀ and myc-␤-TRCP, and GST-Per1 associated proteins were examined for ␤-TRCP binding. We found that the 1-430 fragment (GSTPer1-(1-430)) formed stable complexes with ␤-TRCP1, whereas GST-Per1-(431-830) and GST-Per1-(831-1290) did not (Fig. 4D) . In cycloheximide turnover experiments, we found that GST-Per1-(1-430) was stable when transfected into HEK293 cells, but its steady-state levels as well as its half-life was decreased dramatically when co-expressed with CK1⑀ (Fig. 4F) .
Identification of a Candidate ␤-TRCP1 Interaction Motif in Per1-In order to identify sequences important for interaction of ␤-TRCP1 with Per1, we first performed a deletion analysis of the N-terminal fragment of Per1 that we demonstrated to be sufficient for interaction with ␤-TRCP. ␤-TRCP maintained the ability to associate with Per-(1-373), Per-(1-301), and Per-(1-227) but failed to interact with Per-(1-151) (Fig. 4E ). Given this, we sought to identify sequences in the N-terminal region of Per1 sufficient for binding that maintained features of a ␤-TRCP phosphodegron. Two sequences containing clusters of Ser/Thr residues were found: residues 209 -213 (TSEYT) and residues 121-126 (TSGCSS). Mutation of Ser-210 and Thr-213 to alanine had no effect on the ability of Per1-(1-430) to interact with ␤-TRCP (Fig. 5B) . In contrast, mutation of Thr-121, Ser-122, and Ser-126 to alanine (the Per1 TSS/AAA mutant) greatly reduced binding between Per1-(1-430) and ␤-TRCP1 (Fig. 5B) . Given that Per1-(1-430) is readily degraded in response to co-expression of CK1⑀, we hypothesized that if ␤-TRCPdependent degradation of Per1 involves the TSGCSS motif, then mutation of this motif should render this Per1 mutant insensitive to expression of CK1⑀. As shown in Fig. 5C , this is the case. Overexpression of CK1e greatly reduces the steadystate levels of Per1 and promotes its decay in cycloheximidetreated cells. However, the Per1 TSS/AAA mutant is immune to degradation promoted by CK1⑀. We hypothesize that Thr-121, Ser-122, and Ser-126 are phosphorylated in a CK1⑀-dependent manner and that this mimics the known phosphodegrons for ␤-TRCP, including IB␣, ␤-catenin, and Emi1 (Fig. 5A) .
CK1⑀-dependent Ubiquitination of Per1 by SCF
␤-TRCP in Vitro-We next sought to develop an in vitro ubiquitination assay for Per1. We purified CK1⑀ from baculovirus as a FLAGtagged fusion protein (Fig. 5D) . Addition of FLAG-CK1⑀ to [ 35 S]methionine-labeled Per1 produced in reticulocyte extracts led to reduced mobility, consistent with Per1 phosphorylation by CK1⑀. To examine the ability of ␤-TRCP to promote Per1 ubiquitination, SCF ␤-TRCP complexes were produced in reticulocyte extracts as described (50) and incubated in the absence of added kinase or in the presence of CK1⑀. All reactions contained Ubc5 as a source of ubiquitin-conjugating enzyme activity. In the presence of CK1⑀ and ␤-TRCP, Per1 mobility was dramatically retarded when compared with reactions lacking ␤-TRCP, consistent with ubiquitination (Fig. 5E , compare lane 5 with lane 2). CKII, which has also been implicated in Per1 regulation (23) , was unable to promote Per1 ubiquitination in the presence or absence of ␤-TRCP (Fig. 5E, lanes 3 and 6) .
␤-TRCP Regulates Clock/Bmal-1-dependent TranscriptionPeriod proteins function as repressors of Clock/Bmal-1-dependent genes (8) . Clock and Bmal-1 is a heterodimeric transcription factor that binds to E-box sequences. Upon accumulation of Period in the nucleus, Period interacts with the ClockBmal-1 complex thereby blocking their ability to activate transcription of E-box reporter constructs (19) . If ␤-TRCP controls the abundance of Period proteins, one would expect that alterations in the level or activity of ␤-TRCP would affect the exPer1 Turnover via the SCF ␤-TRCP Ubiquitin Ligase FIG. 4 . The N-terminal region of Per1 is important for the association with ␤-TRCP. A, domain structure and mutagenesis of Period proteins. A schematic representation and its major domains are shown. The locations of GST fusion proteins representing the N-terminal (residues 1-430), central (residues 430 -830), and C-terminal (residues 830 -1290) regions of Per1 are shown. In addition, the alignment of the previously characterized CK1⑀-binding site is shown along with point mutations in phosphorylation sties (28) and CK1⑀-binding sties (57) used in this study. B and C, mutations of conserved residues in the CK1⑀ binding domain do not affect the association of Per1 or Per3 with ␤-TRCP. HEK293T cells were transfected with the vectors expressing Myc-tagged Per1 or Per3 (and mutant proteins wherein putative CK1⑀ phosphorylation sites or binding sites were mutated to alanine) together with the vectors expressing GST-␤-TRCP and GFP-CKI⑀. Thirty hours after transfection, cells were incubated with MG132 for 15 hours prior to harvesting. Association with GST-␤-TRCP was determined after purification with GSH-Sepharose and immunoblotting with the indicated antibodies. D and E, residues 1-227 are sufficient to interact with ␤-TRCP. D, vectors expressing GST, GST-Per1-(1-430), GST-Per1-(431-830), and GST-Per1-(831-1290) were co-transfected with vectors expressing Myc-␤-TRCP and GFP-CK1⑀. After 30 h, cells were supplemented with MG132 for 15 h prior to harvesting. GST-Per1 and associated proteins were purified prior to immunoblotting with the indicated antibodies. E, analogous experiments were performed by using a more refined group of GST-Per1 deletion mutants. GST-Per1-(1-227) maintains the ability to bind to ␤-TRCP, whereas GST-Per1-(1-151) does not. F, Per1-(1-430) contains sufficient information to facilitate CK1⑀-dependent degradation in HEK293T cells. A vector expressing GST-Per1-(1-430) was transfected in the presence or absence of GFP-CK1⑀. After 40 h, CHX was added, and cells were harvested at the indicate times. Extracts were subjected to immunoblotting with anti-GST and anti Cul1 as a loading control. G, wild-type Per3 or Per3 containing nonphosphorylatable residues in candidate CK1⑀ phosphorylation sites (as Myc-tagged protein fusions) were transfected into HEK293T cells in the presence or absence of a vector expressing GFP-CK1e. After 40 h, CHX was added, and samples were harvested at the indicated times prior to immunoblotting. IP, immunoprecipitation; WB, Western blot.
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␤-TRCP Ubiquitin Ligasepression of Clock/Bmal-1-dependent promoters. To examine this question, we first determined the effect of overexpression of ␤-TRCP1 on expression of an E-box luciferase reporter construct containing the mouse arginine vasopressin promoter (19, 58) . The vasopressin promoter construct has been shown to be responsive to the activity of Clock and Period. Accumulation of ␤-TRCP would be expected to promote Period degradation thereby activating Clock/Bmal-1-dependent transcription. As expected, increasing levels of ␤-TRCP1 led to increased levels of transcription with a 3-fold increase observed with 2 g of transfected pCMV-␤-TRCP1 (Fig. 6A) . We considered the possibility that CK1⑀ levels were limiting in the cell and that by providing additional CK1⑀ a larger influence on promoter activation might be observed. In the presence of CK1⑀, an 8-fold increase in reporter activity was observed at 5 g of pCMV-␤-TRCP (Fig. 6A) . These data are consistent with the ability of ␤-TRCP overexpression to promote Per1 ubiquitination and degradation in the presence of CK1⑀. We next examined whether endogenous ␤-TRCP controls the level of transcription of Clock/Bmal-1-dependent transcription in HEK293T cells. Cells were transfected with shRNA vectors that knock down either Fbw7 (shFbw7) or ␤-TRCP (sh␤-TRCP), and the effect on expression of an E-box reporter (4R Luci) was examined (Fig. 6B) . Although suppression of Fbw7 had no effect on luciferase activity, suppression of ␤-TRCP led to a dramatic (10-fold) reduction in the luciferase activity. In contrast, suppression of ␤-TRCP had no effect on a mutant reporter construct lacking the E-box motifs recognized by Clock/ Bmal-1 (Fig. 6B) . Thus, the ability of ␤-TRCP down-regulation to inhibit reporter expression is dependent on sequences that bind Clock/Bmal-1. Taken together with the data presented earlier indicating that suppression of ␤-TRCP stabilizes Per1, we conclude that stabilization of Per1, and possibly other Period proteins expressed in these cells, leads to assembly of Per1 with Clock/Bmal-1 and repression of Clock/Bmal-1-dependent transcription.
DISCUSSION
In this study, we have provided several lines of evidence that indicate a role for ␤-TRCP proteins in control of Per1 turnover in mammalian cells. ␤-TRCP1 and ␤-TRCP2 are closely related in sequence but are encoded by independent genes (40) . We have found that Per1 interacts with both ␤-TRCP1 and ␤-TRCP2 in a manner that depends on casein kinase 1 activity, and depletion of both ␤-TRCP1 and ␤-TRCP2 by RNAi leads to dramatic stabilization of Per1 (Figs. 2 and 3 ). Most studies indicate that ␤-TRCP1 and ␤-TRCP2 are redundant with each other, and depletion of both proteins is normally required for stabilization of targets such as Cdc25A (50, 51) . Consistent with this, ␤-TRCP promotes CK1⑀-dependent ubiquitination of Per1 in vitro (Fig. 5) . Finally, increasing the abundance of ␤-TRCP increases transcription of a clock-dependent reporter construct, whereas depletion of ␤-TRCP leads to repression of clock-dependent genes (Fig. 6) . These results emphasize the importance of Per1 levels and ␤-TRCP/CK1⑀ activity in modulating the activity status of the Per1 protein. The finding that 35 S]methoinine-labeled Per1 was subjected to the ubiquitination of SCF ␤-TRCP complexes assembled in reticulocyte extracts in the presence of purified CKI⑀, CKII, or mock-purified CK1⑀ as described under "Experimental Procedures." Reaction mixtures were subjected to SDS-PAGE and autoradiography.
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␤-TRCP Ubiquitin Ligasemutations in the ␤-TRCP isolog SLMB leads to arrhythmia in Drosophila (22) together with our biochemical and transcriptional data support a role for SCF ␤-TRCP in controlling circadian rhythms across eukaryotes that contain clock mechanisms. In addition, ␤-TRCP has been shown to control rhythms in Neurospora via degradation of the FREQUENCY protein (59).
The precise mechanism by which Per1 interacts with ␤-TRCP is unclear at present. Previous studies have indicated that CK1⑀ interacts with a central region of Period proteins, including Per3 (residues ϳ600 to ϳ800) (28). This region is highly conserved in Period proteins (Fig. 4A) . Several putative CK1 phosphorylation sites in this region of Per3 were found previously to affect weakly Per1 turnover (28) . We have found that mutation in these sites in Per3 or analogous positions in Per1 has no affect on the ability of Period to bind to ␤-TRCP. One of these sites (Ser-662 in Per2) has been found to be mutated to glycine in familial advanced sleep phase syndrome (60) . The finding that ␤-TRCP still associates with Per1 and Per3 mutated in this position and also promotes degradation of this mutant indicates that the S662G mutation does not affect this aspect of Period post-translational control. It is possible that mutation in this site affects other aspects of Period control such as nuclear import, which is also thought to be dependent on CK1 activity. Our results also revealed an unexpected physical and functional interaction between CK1␥2 and Per1. CK1␥2 promoted degradation of Per1 when overexpressed, and RNAi against CK1␥2 stabilized Per1 (Fig. 1, B, D and F) . Previous studies have suggested that CK1␦ can also interact with Period proteins when overexpressed (28) . Under the conditions of our experiments, we did not observe interaction of GFP-CK1␦ with Per1 (Fig. 1) .
Additional work has led to the identification of a sequence motif (Phe-X-X-X-Phe) that interacts with CK1 proteins (57) . The CK1 binding domain of Period proteins contains a highly conserved Phe-X-X-X-Phe motif. Mutation of this motif significantly reduces the association of Per1 with both CK1⑀ and ␤-TRCP, although the interaction is not eliminated. Consistent with the presence of additional CK1⑀ and ␤-TRCP-binding sites in Per1, the N terminus of Per1 (residues 1-480) can be phosphorylated by CK1⑀ in vitro (data not shown) and can associate with ␤-TRCP in vivo in the presence of CK1⑀ (Fig. 4) . Previous work has defined a consensus phosphodegron found in ␤-catenin, IB␣, Emi1, and Emi2 that interacts with ␤-TRCP. This phosphodegron (DpSG⌽XpS, where ⌽ is a hydrophobic amino acid) is not present in Period proteins, suggesting that additional sequence motifs may be capable of interacting with ␤-TRCP in a phosphorylation-dependent manner. Recent data indicate that Wee1 interacts with ␤-TRCP through a nonconsensus motif (56) . Moreover, Xenopus Cdc25A appears to interact with ␤-TRCP through a DDGFLD sequence (61) , indicating that in some circumstances ␤-TRCP can interact with a degron independently of phosphorylation by using acidic amino acids in place of phosphoserine and threonine residues. Through a series of deletion and mutagenesis experiments, we identified a TSGCSS motif (residues 121-126) in Per1 that we propose as a candidate phosphodegron for ␤-TRCP. This sequence is also conserved in Per2, which is regulated in a manner analogous to Per1. We propose that Thr-121, Ser-122, and Ser-126 in Per1 are phosphorylated in a CK1⑀-dependent manner and that these events facilitate interaction with ␤-TRCP. The use of such a motif is consistent with the requirement for glycine in the motif as well as the finding that interaction of ␤-TRCP with substrates requires Arg-474, which interacts with the aspartate residue in canonical substrates such as IB␣ (41) . We hypothesize that phosphothreonine 121 in Per1 would serve this purpose. The inability of Per1-(1-157) to interact with ␤-TRCP may reflect an inability of ␤-TRCP to interact efficiently with and phosphorylate this fragment. Further studies are required to define Per1 phosphorylation in this region.
Although the mechanisms controlling Period turnover are known in outline, many questions remain to be answered, including how phosphorylation controls the subcellular localization of Period and the temporal mechanisms that control repression of clock-dependent genes versus turnover through the ubiquitin pathway. Presumably, degradation occurs after engagement of the Clock transcription complex, but what signals this is not clear. There may also be opportunities for ␤-TRCP-mediated degradation of Per1 both in the cytoplasm and in the nucleus independent of the Clock transcriptional cycle. Development of reagents that allows the localization and phosphorylation status of Period proteins to be determined is required to address these important issues.
